Erytech Pharma. (10/27/16). "Press Release: Erytech Strengthens Executive Leadership Team with Appointments of Chief Scientific Officer and Chief Business Officer". Lyon. |
2016-10-27 |
IFM Therapeutics. (10/26/16). "Press Release: IFM Therapeutics Establishes German Subsidiary and Research Site". Boston, MA & Bonn. |
2016-10-26 |
Evotec AG. (10/26/16). "Press Release: Evotec AG Announces Its Intent to Acquire Cyprotex plc". Hamburg. |
2016-10-26 |
Wilex AG. (10/26/16). "Press Release: Wilex AG. Subsidiary Heidelberg Pharma and Nordic Nanovector Enter into Collaboration to Develop Novel Antibody Drug Conjugates (ADC)". Munich. |
2016-10-26 |
Pieris Pharmaceuticals, Inc.. (10/26/16). "Press Release: Pieris Pharmaceuticals to Receive GLP Tox Milestone Payment in Daiichi Sankyo Collaboration". Boston, MA. |
2016-10-26 |
Pressure BioSciences, Inc.. (10/26/16). "Press Release: Pressure BioSciences’ PCT Platform Featured at Official Launch of Major Cancer Research Center Recently Chosen as a Collaborator in the US »Cancer Moonshot« Initiative". South Easton, MA. |
2016-10-26 |
TATAA Biocenter AB. (10/25/16). "Press Release: TATAA Biocenter and SimplicityBio Announce Complete Solution for Biomarker Discovery, Signature Optimization and Validation". Göteborg & Monthey. |
2016-10-25 |
Debiopharm International SA. (10/25/16). "Press Release: Debiopharm International SA Reaches Important Development Milestones for its Staphylococcus-selective Antibiotic Debio 1450". Lausanne. |
2016-10-25 |
Inositec AG. (10/25/16). "Press Release: Inositec AG Secures CHF1.4 Million in Seed Financing to Advance New Class of Inositol Hexaphosphate-Based Drug Candidates". Haifa. |
2016-10-25 |
Selexis S.A.. (10/25/16). "Press Release: Selexis SA Inks Commercial Cell Line License Agreement with ImmuNext, Inc. for Anti-CD40L Antibody Being Developed for Treatment of Chronic Autoimmune Disorders". Geneva. |
2016-10-25 |
Curetis N.V.. (10/25/16). "Press Release: Curetis Announces Positive Top Line Data from U.S. FDA Trial". Amsterdam & Holzgerlingen. |
2016-10-25 |
PharmaMar S.A.. (10/24/16). "Press Release: PharmaMar Announces the Opening of a New Affiliate in Austria". Madrid. |
2016-10-24 |
University of Mainz (Johannes-Gutenberg-Universität, JGU). (10/24/16). "Press Release: Scientists in Mainz Develop a Novel Method to Benchmark and Improve the Performance of Protein Measurement Techniques. Quantum Leap in the Reliability of Mass Spectrom |
2016-10-24 |
Noxxon Pharma N.V.. (10/24/16). "Press Release: Noxxon Pharma Announces the Implementation of a Liquidity Contract with Invest Securities". Berlin. |
2016-10-24 |
ObsEva S.A.. (10/24/16). "Press Release: ObsEva Announces Results of the IMPLANT Phase 2 Trial of OBE001 (nolasiban) for the Improvement of Pregnancy and Live Birth Rates Following IVF/ICSI". Geneva. |
2016-10-24 |
4SC AG. (10/21/16). "Press Release: Dr Daniel Vitt to Step Down as CDO/CSO and from the Management Board at the End of 2016". Planegg-Martinsried. |
2016-10-21 |
Mologen AG. (10/21/16). "Press Release: Successful Completion of Capital Increase with Substantial Oversubscription [Not for USA, Australia, Canada or Japan, et al.]". |
2016-10-21 |
Sotio a.s.. (10/20/16). "Press Release: Sotio and NBE Therapeutics Sign Collaboration and License Agreement for Next-Generation Antibody-Drug Conjugates". Basel & Prague. |
2016-10-20 |
Debiopharm International SA. (10/20/16). "Press Release: Debiopharm International SA Announces Clinical Collaboration with the Merck-Pfizer Alliance in Cancer Immunotherapy". Lausanne. |
2016-10-20 |
Spectro Analytical Instruments GmbH. (10/20/16). "Press Release: Dr. Christoph Mätzig Named Managing Director, Spectro Analytical Instruments". Kleve. |
2016-10-20 |
Roche. (10/20/16). "Press Release: Roche Delivers Good Sales Growth in the First Nine Months of 2016". Basel. |
2016-10-20 |
Eurofins Scientific. (10/20/16). "Press Release: Over 10% Organic Growth in the First Nine Months of 2016". |
2016-10-20 |
InSphero AG. (10/20/16). "Press Release: 3D Cell Culture Experts Assemble for Inaugural New Frontiers in 3D Conference". Schlieren. |
2016-10-20 |
Mundipharma International Ltd.. (10/19/16). "Press Release: Results from the NOR-SWITCH Study Support Switch from Remicade to Remsima (biosimilar infliximab)". Cambridge. |
2016-10-19 |
Advanced Chemistry Development, Inc. (ACD/Labs). (10/19/16). "Press Release: Schwabe Pharmaceuticals Selects ACD/Labs for Analytical Data Handling and Knowledge Management". Toronto, ON. |
2016-10-19 |
Markes International Ltd.. (10/18/16). "Press Release: Markes International Enhances Its Suite of Thermal Desorption Products with New Sorptive Extraction Technology". Llantrisant. |
2016-10-18 |
ADC Therapeutics S.A.. (10/18/16). "Press Release: ADC Therapeutics Announces Closing of $105 Million Private Financing". Lausanne. |
2016-10-18 |
Protagen AG. (10/18/16). "Press Release: Protagen AG Announces Changes to Their Management Board". |
2016-10-18 |
Ysios Capital. (10/18/16). "Press Release: Ysios Capital Raises €126,4 m ($140 m) for Its Second Fund, Ysios Biofund II Innvierte". Barcelona. |
2016-10-18 |
CRISPR Therapeutics AG. (10/18/16). "Press Release: CRISPR Therapeutics Announces Pricing of Initial Public Offering". Zug & Cambridge, MA. |
2016-10-18 |
Science 37 Inc.. (10/18/16). "Press Release: Science 37 Secures $31m Series B Funding to Expand Clinical Trial Access to Anyone, Anywhere, Anytime". Los Angeles. |
2016-10-18 |
Polyphor Ltd.. (10/18/16). "Press Release: Giacomo Di Nepi Appointed New CEO of Polyphor". Allschwil. |
2016-10-18 |
Hookipa Biotech AG. (10/17/16). "Press Release: Hookipa Secures EUR 4.16 Million Additional Grant Support from the Austrian Research Promotion Agency (FFG) to Develop Arenavirus Vector-based Cancer Immunotherapies". Vienna. |
2016-10-17 |
ObsEva S.A.. (10/17/16). "Press Release: ObsEva Announces Plans to Conduct Initial Public Offering in the United States". Geneva. |
2016-10-17 |
Boehringer Ingelheim. (10/13/16). "Press Release: Boehringer Ingelheim Announces Agreement with Ceva Santé Animale for the Sale of Certain Merial Assets". Ingelheim & Libourne. |
2016-10-13 |
Wilex AG. (10/13/16). "Press Release: Interim Management Statement on the First Nine Months of 2016". Munich. |
2016-10-13 |
Merck KGaA. (10/13/16). "Press Release: Merck Sets Its Sights on 2018 and Outlines Future Strategic Roadmap". Darmstadt. |
2016-10-13 |
Merck KGaA. (10/13/16). "Press Release: Merck Introduces First Certified Spiking Solution of Heavy Labeled Thyroglobulin Protein". Darmstadt. |
2016-10-13 |
TxCell S.A.. (10/13/16). "Press Release: TxCell Appoints Dr. Li Zhou as Vice President Cell Engineering to Lead Its CAR-Treg Programs". Valbonne. |
2016-10-13 |
Scienion AG. (10/12/16). "Press Release: Scienion Opens French Subsidiary Cellenion with Focus on Controlled Cell Dispensing Technologies". Berlin & Lyon. |
2016-10-12 |
Labfolder GmbH. (10/12/16). "Press Release: Labfolder Signs Agreement with Max Planck Society for Organization-wide Use of Laboratory Data Digital Platform". Berlin & Munich. |
2016-10-12 |
CMC Biologics A/S. (10/12/16). "Press Release: CMC Biologics and IDT Biologika Announce the Addition of Cerbios-Pharma and Oncotec Pharma to Their Strategic Collaboration". Copenhagen, Dessau & Lugano. |
2016-10-12 |
HTG Molecular Diagnostics, Inc.. (10/11/16). "Press Release: HTG Molecular Diagnostics and Merck KGaA, Darmstadt, Germany, Enter Into a Master Companion Diagnostics Agreement (UPDATE)". Tucson, AZ. |
2016-10-11 |
Sartorius AG. (10/11/16). "Press Release: CFO Jörg Pfirrmann Has Decided to Leave Sartorius by Mid-2017". Göttingen. |
2016-10-11 |
EffRx Pharmaceuticals S.A.. (10/11/16). "Press Release: Lorenzo Bosisio Appointed CEO of EffRx Pharmaceuticals". Freienbach. |
2016-10-11 |
Transgene S.A.. (10/11/16). "Press Release: Transgene Announces Collaboration with Merck and Pfizer to Evaluate the Combination of TG4001 with Avelumab in HPV-Positive Head & Neck Cancer in a Phase 1/2 Study". Strasbourg. |
2016-10-11 |
Hookipa Biotech AG. (10/11/16). "Press Release: Dr. Torsten Mummenbrauer Appointed SVP Business Development & Licensing of Hookipa Biotech". Vienna. |
2016-10-11 |
Probiodrug AG. (10/11/16). "Press Release: Probiodrug to Present at US and Japanese Life Science Conferences in October 2016". Halle (Saale). |
2016-10-11 |
CureVac AG. (10/11/16). "Press Release: CureVac Appoints Pierre Kemula as Chief Financial Officer". Tübingen. |
2016-10-11 |
PerkinElmer, Inc.. (10/10/16). "Press Release: PerkinElmer's New QSight Triple Quadrupole LC/MS/MS System Delivers High Sensitivity and Enhanced Productivity for Analytical Labs". Waltham, MA & Shanghai. |
2016-10-10 |
Molecular Partners AG. (10/10/16). "Press Release: Molecular Partners’ Strategic Partner Allergan to Present Abicipar Phase 2 Data of PALM Study in Diabetic Macular Edema (DME) at the 2016 AAO Annual Meeting". Zürich-Schlieren. |
2016-10-10 |
IntegraGen S.A.. (10/10/16). "Press Release: New Data on IntegraGen’s miR-31-3p Biomarker Featured in Presentation at 2016 ESMO Congress". Copenhagen. |
2016-10-10 |
Agilent Technologies Inc.. (10/10/16). "Press Release: Agilent Technologies Showcases Innovative Laboratory Solutions at Analytica China 2016". Santa Clara, CA. |
2016-10-10 |
Helsinn Healthcare S.A.. (10/10/16). "Press Release: Helsinn Group Creates New Investment Fund in 40th Anniversary Year". Lugano. |
2016-10-10 |
Selexis S.A.. (10/10/16). "Press Release: Selexis SA Announces Participation at Two Upcoming Industry Conferences". Geneva. |
2016-10-10 |
Nordic Nanovector ASA. (10/10/16). "Press Release: Nordic Nanovector and LegoChem Biosciences Enter Collaboration to Develop Novel Antibody-Drug Conjugates (ADCs) Targeting Leukaemias". Oslo. |
2016-10-10 |
Noxxon Pharma N.V.. (10/10/16). "Press Release: Noxxon Pharma Demonstrates Synergies between NOX-A12 and Therapies Working through T Cells or NK Cells". Berlin. |
2016-10-10 |
Molecular Partners AG. (10/9/16). "Press Release: Molecular Partners Presents Data of MP0250 in an All-comer Phase 1-Study in Solid Tumor Patients and Updates on Phase 2 Studies". Zürich-Schlieren. |
2016-10-09 |
Newron Pharmaceuticals S.p.A.. (10/7/16). "Press Release: Newron Raises CHF26.1 Mio. in a Private Placement of New Shares [Not for release, publication or distribution, directly or indirectly, in the United States of America, Canada, Japan or Australia]" |
2016-10-07 |
Ionicon Analytik GmbH. (10/7/16). "Press Release: Ionicon Celebrates Historic Milestone. 300 PTR-MS Instruments Sold". Innsbruck. |
2016-10-07 |
Merck KGaA. (10/6/16). "Press Release: Merck Unveils New State-of-the-Art M Lab Collaboration Center in Korea". Incheon. |
2016-10-06 |
Bruker Corporation. (10/6/16). "Press Release: Bruker Introduces Enhanced Wine-Profiling Module 3.1 for its NMR FoodScreener". Billerica, MA. |
2016-10-06 |
Probiodrug AG. (10/6/16). "Press Release: Probiodrug Announces Pricing of a EUR 14.9 Million Accelerated Bookbuild Offering of New Shares [NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA]". Halle (Saale). |
2016-10-06 |
Thermosome GmbH. (10/6/16). "Press Release: Thermosome Appoints Dr. Ulrich Grau, Dr. Jochen Knolle and Dr. Franz-Robert Klingan to Its Advisory Board". Martinsried. |
2016-10-06 |
Vaccinex Inc.. (10/6/16). "Press Release: Vaccinex Announces Clinical Collaboration with Merck KGaA, Darmstadt, Germany, to Evaluate the Combination of VX15/2503, and Avelumab in Non-Small Cell Lung Cancer". Rochester, NY. |
2016-10-06 |
Novaliq GmbH. (10/6/16). "Press Release: Novaliq Strengthens Executive Management Team by Appointing Christian Roesky, PhD, as Chief Executive Officer". Heidelberg. |
2016-10-06 |
Kite Pharma, Inc.. (10/6/16). "Press Release: Kite Pharma Initiates Phase 1b/2 Combination Study for KTE-C19 and Atezolizumab in Patients with Refractory Diffuse Large B-cell Lymphoma (DLBCL)". Santa Monica, CA. |
2016-10-06 |
Molecular Partners AG. (10/6/16). "Press Release: Molecular Partners Regains Rights to Multi-DARPin Drug Candidate Targeting IL-13 & IL-17 for Pulmonary Indications from Janssen". Zürich-Schlieren. |
2016-10-06 |
SGS S.A.. (10/6/16). "Press Release: SGS Investment Launches Precision Agriculture Services In Brazil". |
2016-10-06 |
Probiodrug AG. (10/5/16). "Press Release: Probiodrug Launches Capital Increase by Means of an Accelerated Bookbuild Offering [NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA]". Halle (Saale). |
2016-10-05 |
Advanced Accelerator Applications S.A.. (10/5/16). "Press Release: Advanced Accelerator Applications S.A. Announces Pricing of $150 Million Public Offering of American Depositary Shares". New York, NY. |
2016-10-05 |
PX’Therapeutics S.A.. (10/5/16). "Press Release: PX’Therapeutics and Relief Therapeutics Holding AG Announce a Strategic Collaboration Agreement for the Recombinant Production of Atexakin Alfa". Grenoble & Geneva. |
2016-10-05 |
Biodesix, Inc.. (10/5/16). "Press Release: VeriStrat Test Identifies Patients with Squamous Cell Carcinoma of the Lung Who Are More Likely to Have Improved Survival on Afatinib Therapy". Boulder, CO. |
2016-10-05 |
Mayoly Spindler. (10/5/16). "Press Release: Mayoly Spindler Acquires the Swedish Laboratory Kibion". Paris. |
2016-10-05 |
Genedata AG. (10/4/16). "Press Release: Genedata Screener 14 Raises the Bar on Efficiency and Workflow Support". Basel. |
2016-10-04 |
Evotec AG. (10/4/16). "Press Release: Evotec and Carrick Therapeutics Build Strategic Alliance". Hamburg. |
2016-10-04 |
Grünenthal GmbH. (10/4/16). "Press Release: Gabriel Baertschi Takes Office as New CEO of Grünenthal Group as of October 1, 2016". Aachen. |
2016-10-04 |
Curetis N.V.. (10/4/16). "Press Release: Curetis to Present at Several Investor and Scientific Conferences in the Fourth Quarter 2016". Amsterdam & Holzgerlingen. |
2016-10-04 |
Carrick Therapeutics Ltd.. (10/3/16). "Press Release: Launch of Carrick Therapeutics Signals New Approach to Cancer Therapies. $95m Initial Funding from Leading Investor Syndicate". Dublin. |
2016-10-03 |
Tecan Group Ltd.. (10/3/16). "Press Release: Tecan Successfully Completes the Acquisition of SPEware Corporation". Männedorf. |
2016-10-03 |
SGS S.A.. (10/3/16). "Press Release: SGS Announces Investment in New cGMP Facility in Berlin, Germany". |
2016-10-03 |
Janssen Research & Development, LLC. (10/1/16). "Press Release: New Phase 3 Data Show Significant Efficacy versus Placebo and Superiority of Guselkumab versus Humira in Treatment of Moderate to Severa Plaque Psoriasis". Vienna. |
2016-10-01 |
MorphoSys AG. (10/1/16). "Press Release: MorphoSys Announces that Its Licensee Janssen Reports Positive Results from a Phase 3 Study of Guselkumab in Plaque Psoriasis". |
2016-10-01 |
Boehringer Ingelheim. (9/30/16). "Press Release: Boehringer Ingelheim Returns Development and Commercial Rights of Olmutinib to Hanmi Pharmaceutical". Ingelheim. |
2016-09-30 |
Sanofi S.A.. (9/30/16). "Press Release: Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare". Paris. |
2016-09-30 |
Grünenthal GmbH. (9/30/16). "Press Release: Grünenthal’s Cebranopadol, a Novel Strong Analgesic, Meets Pimary Efficacy Endpoint in Phase 3 Trial in Cancer Pain". Yokohama. |
2016-09-30 |
Qiagen N.V.. (9/29/16). "Press Release: Qiagen and ICMP to Develop First NGS Workflow for Identification of Missing Persons". Hilden & The Hague. |
2016-09-29 |
GlaxoSmithKline plc. (9/29/16). "Press Release: GlaxoSmithKline plc Appoints Brian McNamara as CEO of GSK Consumer Healthcare". London. |
2016-09-29 |
Evotec AG. (9/29/16). "Press Release: Evotec Receives further Important Pre-clinical Milestone in Endometriosis Alliance with Bayer". Hamburg. |
2016-09-29 |
Boehringer Ingelheim. (9/29/16). "Press Release: Boehringer Ingelheim and Sarah Cannon Research Institute Launch Strategic Collaboration to Develop Novel Immune-oncology Therapies". Ingelheim. |
2016-09-29 |
DelSiTech Ltd.. (9/29/16). "Press Release: DelSiTech Ltd and Bayer Partner to Develop Innovative Drug Delivery Technology for Ophthalmology". Turku. |
2016-09-29 |
Medigene AG. (9/29/16). "Press Release: Bluebird Bio and Medigene Establish Strategic T Cell Receptor (TCR) Alliance in Cancer Immunotherapy". Martinsried & Cambridge, MA. |
2016-09-29 |
MorphoSys AG. (9/29/16). "Press Release: MorphoSys and Galapagos Start First-in-Patient Dosing of IL-17C Antibody MOR106 in Atopic Dermatitis". |
2016-09-29 |
Immunic AG. (9/28/16). "Press Release: Immunic Acquires 4SC’s Immunology Portfolio". Planegg-Martinsried. |
2016-09-28 |
Evotec AG. (9/28/16). "Press Release: Evotec Enters into Strategic Multi-target Alliance with C4X Discovery". Hamburg. |
2016-09-28 |
Boehringer Ingelheim. (9/28/16). "Press Release: Boehringer Ingelheim Boosts Immune-oncology Pipeline through Collaboration with ViraTherapeutics". Ingelheim. |
2016-09-28 |
Merck KGaA. (9/28/16). "Press Release: Merck to Present New Research Focused on Hard-to-Treat Cancers at ESMO 2016 [Not for U.S. and UK media]". Darmstadt. |
2016-09-28 |
Noxxon Pharma N.V.. (9/28/16). "Press Release: Noxxon Pharma NV Lists Its Shares on Alternext Paris [Not for United States, Australia, Canada or Japan or any other jurisdiction where unlawful]". Berlin. |
2016-09-28 |
Wilex AG. (9/27/16). "Press Release: Subsidiary Heidelberg Pharma Contracts Suisse CDMO Celonic for Antibody Cell Line Development and Antibody Production". Munich. |
2016-09-27 |
Immunic AG. (9/27/16). "Press Release: Immunic Successfully Closes 17.5 Million Euro Series A Financing Round". Planegg-Martinsried. |
2016-09-27 |